HCM · NASDAQ · Drug Manufacturers - Specialty & Generic

HUTCHMED (ADR)

Develops targeted therapies and immunotherapies, commercializing medicines in China and through global partners.

$12.31
After-hours close−0.06 (−0.49%)
At close$12.37(−0.36%)

Breakdown13F · Form 4

Institutions 2.45%Insiders

Shares outstanding 174.47M · Float 170.46M · 97.7% free float

Insiders — filings are in the shares behind the receipt.

This listing is a depositary receipt and the Form 4 positions here are filed in the shares behind it, a different unit from the share count and in a ratio the filings never state, so no insider percentage is shown.

Top shareholders13F · 13D/G · Form 4

HolderShares% outstandingFormFiled
Schroder Investment Management Group1.48M0.85%13FMay 14, 2026
Allianz Asset Management GmbH837.5K0.48%13FMay 11, 2026
State Street Corp304.8K0.17%13FMay 15, 2026
Aia Group Ltd291.2K0.17%13FMay 6, 2026
M&G PLC255.5K0.15%13FMay 13, 2026

Institutions13F, as of Mar 31, 2026

53 holders · 4.27M shares · 10 new positions · 24 increased · 18 reduced · 5 closed

HolderShares% outstandingChg q/qFiled
Schroder Investment Management Group1.48M0.85%−802.0KMay 14, 2026
Allianz Asset Management GmbH837.5K0.48%−71.3KMay 11, 2026
State Street Corp304.8K0.17%−16.5KMay 15, 2026
Aia Group Ltd291.2K0.17%−24.2KMay 6, 2026
M&G PLC255.5K0.15%−3.6KMay 13, 2026
Amundi232.2K0.13%+8.9KMay 18, 2026
Renaissance Technologies LLC132.1K0.08%−2.8KMay 14, 2026
BNP Paribas Arbitrage, SNC106.5K0.06%+75.1KMay 12, 2026

Beneficial owners13D/G · 5% or more, as filed

No 13D/G filer at 5% or more on record.

InsidersForm 4

InsiderRoleSharesFiled
Wei-guo Sudirector, officer: CEO and CSO237.1KMar 16, 2026
Edith Shihdirector100.0KMar 10, 2026
Chig Fung Chengdirector, officer: Chief Financial Officer56.7KMar 11, 2026
Charles George Rupert Nixonofficer: Group General Counsel41.8KMar 31, 2026
Tony Shu Kam Mokdirector27.3KMar 10, 2026
Dan Eldardirector26.3KMar 10, 2026
Lorenso Chiuofficer: Deputy Chief Financial Officer8.5KMar 18, 2026

7 positions are filed in the unlisted share unit (5.95M shares), which no share count here divides

Latest trades

No open-market trades in the last 12 months.

CongressHouse and Senate disclosures

Not reported.